![Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile](https://www.researchgate.net/publication/372169980/figure/fig1/AS:11431281173178904@1688786663855/ntratumoral-detection-of-Nivolumab-and-tissue-resident-T-cells-a-Illustrative_Q320.jpg)
Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile
![Ulrik Lassen on X: "Professor Per Sjøgren received the honorary prize of the Danish Cancer Society during his farewell symposium celebrating a fantastic career. The prize is also awarded to professor Mogens Ulrik Lassen on X: "Professor Per Sjøgren received the honorary prize of the Danish Cancer Society during his farewell symposium celebrating a fantastic career. The prize is also awarded to professor Mogens](https://pbs.twimg.com/media/FJoAzXoWUAQ6oW3.jpg:large)
Ulrik Lassen on X: "Professor Per Sjøgren received the honorary prize of the Danish Cancer Society during his farewell symposium celebrating a fantastic career. The prize is also awarded to professor Mogens
![Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile](https://www.researchgate.net/publication/372169980/figure/fig3/AS:11431281173197106@1688786664054/Nivolumab-induced-differentiation-of-T-cells-a-The-kinetics-of-Nivolumab-binding-CD8_Q320.jpg)
Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile
Ulrik Lassen email address & phone number | Rigshospitalet Head Of Department of Oncology contact information - RocketReach
![Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile](https://www.researchgate.net/publication/372169980/figure/fig5/AS:11431281173178905@1688786664312/Comparison-of-patients-with-reactive-T-cells-versus-non-reactive-T-cells-a-Reactivity_Q320.jpg)
Ulrik LASSEN | Rigshospitalet, Copenhagen | rigshospitalet | Department of Oncology | Research profile
![Ulrik Lassen email address & phone number | Rigshospitalet Head Of Department of Oncology contact information - RocketReach Ulrik Lassen email address & phone number | Rigshospitalet Head Of Department of Oncology contact information - RocketReach](https://d1hbpr09pwz0sk.cloudfront.net/profile_pic/per-christiansen-hospitalsdirektor-rigshospitalet-283127fc.jpg)
Ulrik Lassen email address & phone number | Rigshospitalet Head Of Department of Oncology contact information - RocketReach
![PDF) Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients PDF) Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients](https://i1.rgstatic.net/publication/333715719_Plasma_total_cell-free_DNA_is_a_prognostic_biomarker_of_overall_survival_in_metastatic_solid_tumour_patients/links/5ef2db9092851cba7a46129c/largepreview.png)
PDF) Plasma total cell-free DNA is a prognostic biomarker of overall survival in metastatic solid tumour patients
![Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial | Nature Medicine Dabrafenib plus trametinib in BRAFV600E-mutated rare cancers: the phase 2 ROAR trial | Nature Medicine](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41591-023-02321-8/MediaObjects/41591_2023_2321_Fig1_HTML.png)